Supernus Pharmaceuticals, Inc. (SUPN)
46.10
+0.68
(+1.50%)
USD |
NASDAQ |
Dec 10, 16:00
46.10
0.00 (0.00%)
After-Hours: 19:46
Supernus Pharmaceuticals Market Cap: 2.643B for Dec. 10, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Biogen, Inc. | 26.04B |
| BridgeBio Pharma, Inc. | 14.01B |
| CorMedix, Inc. | 904.89M |
| Assembly Biosciences, Inc. | 569.10M |
| Viking Therapeutics, Inc. | 4.242B |
Market Cap Related Metrics
| PS Ratio | 3.814 |
| Price to Book Value | 2.518 |
| Price to Free Cash Flow | 36.74 |
| Price | 46.10 |
| Earnings Yield | -0.74% |